Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
In the 1990s, researchers at Novo Nordisk in Denmark, including Lotte Bjerre Knudsen, drew inspiration from the Gila monster's venom protein Exendin-4 and successfully developed the first GLP-1 drug, exenatide
It was found that even in aged mice, an improvement in memory formation was observed, and LTP in area CA1 was found to be strong and enduring in drug-treated AD mice but lacking in saline-treated AD mice
In addition, BluVial 1mg Injection is used to treat noncirrhotic nonalcoholic steatohepatitis (NASH) in adults who have moderate to advanced liver scarring
PubMed Jiang H, Shi J, Li Y
Multiple Benefits There is no denying the tremendous results from these medications
Still, the analysts predicted that Ozempic, Wegovy, and Rybelsus (semaglutide) maker Novo Nordisk and Eli Lilly, which developed Zepbound and Mounjaro (tirzepatide), will maintain two-thirds of the market by 2031 due to their first-mover advantages. Other competitors are expected to take a combined $70 billion of the GLP-1 market, the study read
